At a glance
ClinicalIndex Comparison RecordN/ACompleted· 95 enrolled
Drug / intervention
0 degrees humeral component version +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact of Humeral Component Version on Outcomes Following Reverse Total Shoulder Arthroplasty: A Prospective Randomized Controlled Trial
In Brief
A clinical study evaluating 0 degrees humeral component version and 30 degrees humeral component retroversion for Rotator Cuff Tear Arthropathy. Completed, enrolled 95 participants across 1 site.
Detailed Summary
The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRotator Cuff Tear Arthropathy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartMay 2017
Primary CompletionMay 2023
TodayJul 2026
First PostedApr 12, 2017
Enrollment StartMay 12, 2017
Primary CompletionMay 23, 2023
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 9.2 years ago
Interventions
0 degrees humeral component versiondevice
RTSA with humeral component positioned in 0 degrees of version
30 degrees humeral component retroversiondevice
RTSA with humeral component positioned in 30 degrees of retroversion